Literature DB >> 25465389

Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis.

Timothy J Sontag1, Bijoy Chellan1, Clarissa V Bhanvadia1, Godfrey S Getz1, Catherine A Reardon1.   

Abstract

Macrophage conversion to atherosclerotic foam cells is partly due to the balance of uptake and efflux of cholesterol. Cholesterol efflux from cells by HDL and its apoproteins for subsequent hepatic elimination is known as reverse cholesterol transport. Numerous methods have been developed to measure in vivo macrophage cholesterol efflux. Most methods do not allow for macrophage recovery for analysis of changes in cellular cholesterol status. We describe a novel method for measuring cellular cholesterol balance using the in vivo entrapment of macrophages in alginate, which retains incorporated cells while being permeable to lipoproteins. Recipient mice were injected subcutaneously with CaCl2 forming a bubble into which a macrophage/alginate suspension was injected, entrapping the macrophages. Cells were recovered after 24 h. Cellular free and esterified cholesterol mass were determined enzymatically and normalized to cellular protein. Both normal and cholesterol loaded macrophages undergo measureable changes in cell cholesterol when injected into WT and apoA-I-, LDL-receptor-, or apoE-deficient mice. Cellular cholesterol balance is dependent on initial cellular cholesterol status, macrophage cholesterol transporter expression, and apolipoprotein deficiency. Alginate entrapment allows for the in vivo measurement of macrophage cholesterol homeostasis and is a novel platform for investigating the role of genetics and therapeutic interventions in atherogenesis.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  alginate; apolipoproteins; atherosclerosis; cholesterol/trafficking; high density lipoprotein; low density lipoprotein

Mesh:

Substances:

Year:  2014        PMID: 25465389      PMCID: PMC4306700          DOI: 10.1194/jlr.D052985

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  54 in total

1.  Cell encapsulation: promise and progress.

Authors:  Gorka Orive; Rosa María Hernández; Alicia R Gascón; Riccardo Calafiore; Thomas M S Chang; Paul De Vos; Gonzalo Hortelano; David Hunkeler; Igor Lacík; A M James Shapiro; José Luis Pedraz
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

Review 2.  In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection.

Authors:  Joan Carles Escolà-Gil; Noemí Rotllan; Josep Julve; Francisco Blanco-Vaca
Journal:  Atherosclerosis       Date:  2009-03-21       Impact factor: 5.162

3.  Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma.

Authors:  S C Whitman; C A Argmann; C G Sawyez; D B Miller; R A Hegele; M W Huff
Journal:  J Lipid Res       Date:  1999-06       Impact factor: 5.922

4.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

5.  The LDL receptor is the major pathway for beta-VLDL uptake by mouse peritoneal macrophages.

Authors:  S Perrey; S Ishibashi; T Kitamine; J Osuga; H Yagyu; Z Chen; F Shionoiri; Y Iizuka; N Yahagi; Y Tamura; K Ohashi; K Harada; T Gotoda; N Yamada
Journal:  Atherosclerosis       Date:  2001-01       Impact factor: 5.162

6.  Investigation on a novel core-coated microspheres protein delivery system.

Authors:  S Zhou; X Deng; X Li
Journal:  J Control Release       Date:  2001-07-10       Impact factor: 9.776

7.  Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.

Authors:  Xun Wang; Heidi L Collins; Mollie Ranalletta; Ilia V Fuki; Jeffrey T Billheimer; George H Rothblat; Alan R Tall; Daniel J Rader
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

8.  The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.

Authors:  Urbain Tchoua; Wilissa D'Souza; Nigora Mukhamedova; Denise Blum; Eric Niesor; Jacques Mizrahi; Cyrille Maugeais; Dmitri Sviridov
Journal:  Cardiovasc Res       Date:  2007-12-04       Impact factor: 10.787

9.  In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired.

Authors:  Ming-Dong Wang; Vivian Franklin; Yves L Marcel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-31       Impact factor: 8.311

10.  The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A.

Authors:  Maria C de Beer; Joanne M Wroblewski; Victoria P Noffsinger; Ailing Ji; Jason M Meyer; Deneys R van der Westhuyzen; Frederick C de Beer; Nancy R Webb
Journal:  J Lipids       Date:  2013-01-30
View more
  2 in total

Review 1.  Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis?

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-07       Impact factor: 8.311

Review 2.  Apoprotein E and Reverse Cholesterol Transport.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.